342 related articles for article (PubMed ID: 12708999)
1. Mycosis fungoides associated with malignant melanoma and dysplastic nevus syndrome.
Pielop JA; Brownell I; Duvic M
Int J Dermatol; 2003 Feb; 42(2):116-22. PubMed ID: 12708999
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous malignant melanoma in association with mycosis fungoides.
Evans AV; Scarisbrick JJ; Child FJ; Acland KM; Whittaker SJ; Russell-Jones R
J Am Acad Dermatol; 2004 May; 50(5):701-5. PubMed ID: 15097953
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
4. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
6. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
7. Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma.
Goyal A; O'Leary D; Goyal K; Rubin N; Janakiram M
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1821-1829. PubMed ID: 34013554
[TBL] [Abstract][Full Text] [Related]
8. Melanoma Risk is Increased in Patients with Mycosis Fungoides Compared with Patients with Psoriasis and the General Population.
Sherman S; Kremer N; Dalal A; Solomon-Cohen E; Berkovich E; Noyman Y; Ben-Lassan M; Levi A; Pavlovsky L; Prag Naveh H; Hodak E; Amitay-Laish I
Acta Derm Venereol; 2020 Dec; 100(19):adv00346. PubMed ID: 33241425
[TBL] [Abstract][Full Text] [Related]
9. Rare cutaneous malignancies of childhood.
Hoang MT; Friedlander SF
Curr Opin Pediatr; 1999 Oct; 11(5):464-70. PubMed ID: 10555600
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia: clinical characteristics, temporal relationships, and survival data in a series of 14 patients at Mayo Clinic.
Chang MB; Weaver AL; Brewer JD
Int J Dermatol; 2014 Aug; 53(8):966-70. PubMed ID: 24134412
[TBL] [Abstract][Full Text] [Related]
11. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
12. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.
Lindahl LM; Fenger-Grøn M; Iversen L
Br J Dermatol; 2014 Mar; 170(3):699-704. PubMed ID: 24024659
[TBL] [Abstract][Full Text] [Related]
13. The different faces of mycosis fungoides: results of a single-center study.
Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
15. [Mycosis fungoides and B-cell chronic lymphocytic leukemia: an extremely rare coincidence].
Süss A; Wetzig T; Sticherling M; Tannapfel A; Simon JC
Hautarzt; 2006 Oct; 57(10):888-92. PubMed ID: 16408218
[TBL] [Abstract][Full Text] [Related]
16. Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia.
Miyatake J; Inoue H; Serizawa K; Morita Y; Espinoza JL; Tanaka H; Shimada T; Tatsumi Y; Ashida T; Matsumura I
Intern Med; 2018 May; 57(10):1445-1453. PubMed ID: 29321428
[TBL] [Abstract][Full Text] [Related]
17. Histologic features of melanocytic nevi seen in association with mycosis fungoides.
McNiff JM; Glusac EJ
J Cutan Pathol; 2003 Nov; 30(10):606-10. PubMed ID: 14744084
[TBL] [Abstract][Full Text] [Related]
18. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
19. Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study.
Geller S; Gomez CJ; Myskowski PL; Pulitzer M
J Am Acad Dermatol; 2019 Jun; 80(6):1704-1711. PubMed ID: 30716405
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of treatments for mycosis fungoides and Sézary syndrome: nationwide survey responses.
Gettler SL; Fung MA
Dermatol Online J; 2005 Dec; 11(3):6. PubMed ID: 16409902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
